Science 37 has unveiled a new patient relationship management and contact centre technology that aims to enhance patient engagement, thereby expediting recruitment and improving enrolment conversion rates.

With the help of this platform, media planning, reporting, placement, and participant communications can be carried out with substantial efficiency to obtain quicker and enhanced patient recruitment into clinical trials.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The platform can also aid in curating content which can be used to boost engagement amongst the current patient community of the company.

On showing interest in a trial, the new contact centre technology provides near and real-time dialogue, across various channels of communication, between an eligible patient and a remote trial coordinator.

This approach aids in guaranteeing that the eligible patients willing to take part have every opportunity to enrol into the trial.

Science 37 chief delivery officer Darcy Forman said: “Our new investments in patient relationship management and contact centre technology enables us to significantly improve the speed and cost to recruit patients, in addition to our conversion rates from contact to consent.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“While study sponsors often deploy multi-channel approaches to drive patients from outside an investigator’s practice into brick-and-mortar sites, traditional sites have a poor track record in enrolling these referrals into the study because the site’s lack the focus and processes to be successful.

“The Science 37 enrolment model is fully designed with the mindset that no patient should be left behind.”

Participant enrolment in clinical research is the key driver for delays in clinical trials, representing nearly 80% of all trials.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact